MedTrace Logo

Informational Nudge to Improve Heart Failure Prescribing

NCT05986695 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2026-05-01

Study results available
· View outcomes & findings →

Summary

This study addresses a critical gap of care for Veterans with heart failure (HF). Only 1/3 or fewer eligible Veterans are receiving recommended SGLT2 and MRA therapies that save lives and prevents HF hospitalizations. The investigators will compare the effect of clinician directed nudges as strategies to improve the health of Veterans with HF.

Conditions

Interventions

BEHAVIORAL

Alert

Interruptive alert. The prototype alert is in the form of a chart note with evidence-based practice guidelines that will actively display in the clinician's list of daily alerts (like an inbox) that must be cleared daily. It is interruptive because can only be dismissed from the clinician's inbox list after signing the note

BEHAVIORAL

Peer comparison report

Clinicians will receive an email describing their recent SGLT2 and MRA prescribing performance relative to their peers.

Sponsors & Collaborators

  • Arizona State University

    collaborator OTHER

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Sandesh Dev, MD · Southern Arizona VA Health Care System, Tucson, AZ

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-09
Primary Completion
2024-10-31
Completion
2024-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05986695 on ClinicalTrials.gov